Hyoscine in labour
Not Applicable
- Conditions
- Pregnancy and Childbirth
- Registration Number
- PACTR201808146688942
- Lead Sponsor
- Akiseku Adeniyi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 126
Inclusion Criteria
Nulliparity
•Singleton foetus at a gestational age between 37- 42 weeks
•Cephalic presentation
•Spontaneous active phase of labour with cervical dilatation 4cm
•Booked Patients
Exclusion Criteria
History of allergy to Buscopan
•Previous uterine scar
•Malpresentation
•Twin gestation
•Prior prolonged rupture of membrane
•Antepartum haemorrhage
•Contracted pelvis
•Pre-eclampsia and other hypertensive diseases in labour
•Other medical conditions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Determine the duration of first stage (active phase) of labour among parturients administered with Hyoscine-N- Butylbromide (Injection Buscopan) and compare with suitably matched controls administered with placebo.
- Secondary Outcome Measures
Name Time Method To compare the foetal outcome of parturients administered with Hyoscine-N- Butylbromide (Injection Buscopan) and suitably matched controls administered with placebo.